DECODE Antigen
Through DECODE Antigen, we assess the presentation of disease-associated antigens across many different MHC molecules. This allows us to determine which antigens are presented across diverse patient populations. We believe this will allow us to target our T cell product candidates to the right antigens presented on the surface of the specific MHC Class II molecules, which are risk factors for autoimmune disease.